Skip to main content

Table 2 Baseline characteristics according to single-vessel or multi-vessel CAD

From: Association between the triglyceride–glucose index and severity of coronary artery disease

 

Total

(n = 2792)

Single-vessel CAD

(n = 633)

Multi-vessel CAD

(n = 2159)

P-value

Age (years)

66 ± 10

65 ± 10

66 ± 10

 < 0.01

Male (n,%)

1927 (69.02%)

359 (56.71%)

1568 (72.62%)

 < 0.01

SBP (mmHg)

136 ± 18

136 ± 18

135 ± 18

0.58

DBP (mmHg)

77 ± 12

77 ± 11

77 ± 12

0.56

FPG (mmol/l)

6.36 ± 2.22

5.92 ± 1.68

6.49 ± 2.34

 < 0.01

BMI (Kg/m2)

25.71 ± 3.34

25.79 ± 3.38

25.68 ± 3.32

 < 0.01

HDL-C (mg/dL)

1.04 ± 0.25

1.10 ± 0.27

1.03 ± 0.25

0.92

LDL-C (mg/dL)

2.12 ± 0.80

2.12 ± 0.78

2.12 ± 0.81

0.92

TC (mg/dL)

3.72 ± 0.93

3.77 ± 0.90

3.71 ± 0.94

0.17

HbA1c (%)

6.59 ± 1.23

6.33 ± 1.03

6.67 ± 1.27

 < 0.01

eGFR

85.97 ± 17.08

88.88 ± 14.02

85.11 ± 17.79

 < 0.01

Smoking (n, %)

1299 (46.53%)

250 (39.49%)

1049 (48.59%)

 < 0.01

Drinking (n, %)

1771 (63.43%)

394 (62.24%)

1377 (63.78%)

0.48

Hypertension (n, %)

1949 (69.81%)

412 (65.09%)

1537 (71.19%)

 < 0.01

Glucose metabolism state

 NGR (n, %)

530 (18.98%)

157 (24.80%)

373 (17.28%)

 < 0.01

 Pre-DM (n, %)

1038 (37.8%)

257 (40.60%)

781 (36.17%)

 < 0.01

 DM (n, %)

1224 (43.84%)

219 (34.60%)

1005 (46.55%)

 < 0.01

Medications

 Antiplatelets (n, %)

2643 (94.66%)

595 (94.00%)

2048 (94.86%)

0.40

 Antihypertensive drugs (n, %)

2317 (82.99%)

491 (77.57%)

1826 (84.58%)

 < 0.01

 Antilipidemic drugs (n, %)

2629 (94.16%)

590 (93.21%)

2039 (94.44%)

0.25

  1. SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, BMI body mass index, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TC total cholesterol, HbA1c glycated hemoglobin A1c, eGFR estimated glomerular filtration rate, NGR normoglycemia, Pre-DM pre-diabetes mellitus, DM diabetes mellitus, CAD coronary artery disease